These data indicate that in β-catenin-activated tumours, the immune environment is heterogeneous, with the immune response possibly influenced by a shift in balance between the immunosuppressive effects of Wnt/β-catenin and the pro-inflammatory IFN pathway. This evidence concerns the gene IFNA1 and neoplasm.